Siponimod trial ‘first’ to show delayed disability in secondary progressive MSMarch 22, 2018Multiple Sclerosis
MRI finds PML in some natalizumab-treated patients despite negative CSF, no symptomsMarch 20, 2018Multiple Sclerosis
Researchers find predictors of worse MS outcomes in post hoc study of three trialsFebruary 28, 2018Multiple Sclerosis
Fingolimod switch from an injectable linked to improved outcomes in relapsing MSFebruary 26, 2018Multiple Sclerosis
Extended-interval dosing of natalizumab linked to lower risk of PMLFebruary 22, 2018Multiple Sclerosis
Do Neurologists Adequately Screen Patients With MS for Cognitive Impairment and Depression?February 14, 2018Multiple Sclerosis
